RankAlpha logo
Back to Rankings

ANVS

Annovis BioD
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ANVS vs peer average
40/100
ANVS vs. peer average (D vs. C)
Grade spread
A 3 · B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

RDY is the first available peer comparator.

Small-cap biotech with early-stage CNS programs; serves as a comparable for development-stage binary risk.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRDYDr Reddy's Laboratories
ANVS
Annovis Bio
RDY
Dr Reddy's Laboratories
Grade
D
A
Momentum
13
83
Value
41
64
Sentiment
50
53
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs RDY

ANVS / RDY
Grade Position
Below peers
ANVS vs. peer average (D vs. C)
40/100
Momentum
13
RDY
Value
41
RDY
Sentiment
50
RDY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ANVS
1
RDY
RDY
A
100/100
+3
2
ALZN
ALZN
F
20/100
-1
3
NERV
NERV
C
60/100
+1
4
TVGN
Tevogen Inc Common
F
20/100
-1
5
ESLA
Estrella Immunopharma Inc Common
F
20/100
-1
RDY is the first peer returned for this comparison set.